Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2014

Every FDA drug recall initiated in 2014, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,309 recalls, newest first.

Class II · Moderate risk

Lidocaine 4% Syr

Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility of their products.

Terminated Sterility / contamination Vann Healthcare Services Inc D-0311-2015
Class II · Moderate risk

Epinephrine 1:1000

Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility of their products.

Terminated Sterility / contamination Vann Healthcare Services Inc D-0310-2015
Class II · Moderate risk

Hydroxyprogesterone Caproate

Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility of their products.

Terminated Sterility / contamination Vann Healthcare Services Inc D-0309-2015
Class II · Moderate risk

Sterile Water for Injection

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7990-09 D-0287-2015
Class II · Moderate risk

0.45% Sodium Chloride Injection

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7985-09 D-0286-2015
Class II · Moderate risk

0.9% Sodium Chloride Injection

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7983-09 D-0285-2015
Class II · Moderate risk

Lactated Ringer's Injection

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7953-09 D-0283-2015
Class II · Moderate risk

5% Dextrose Injection

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7922-09 D-0279-2015
Class II · Moderate risk

Assured Naproxen Sodium Tablets

Correct Labeled Product Mispacked; correct labeled bottles of Assured Ibuprofen softgels were packaged into cartons of Assured Naproxen Sodium Tablets, USP

Terminated Labeling / mix-up Contract Packaging Resources Inc. D-0248-2015
Class III · Low risk

TORISEL Kit

Crystallization: Impurities in a raw material used to manufacture the diluent can cause the formation of crystals in the diluent vials after cold storage. The TORISEL vials are not affected by this issue.

Terminated Failed specification Pfizer Inc. NDC 0008-1179-01 D-0235-2015
Class II · Moderate risk

Glimepiride Tablets

Failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during stability testing.

Terminated Stability / shelf life Micro Labs Usa, Inc S NDC 42571-101-01 D-0046-2015
Class II · Moderate risk

Vitamin B Complex

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Terminated Sterility / contamination Oregon Compounding Centers, Inc. dba Creative Compounds D-0228-2015

Recalls by year